BIOCARTIS Sustainability Profile
BIOCARTIS, headquartered in Belgium, is a pioneering molecular diagnostics company that has been at the forefront of personalised medicine since its founding in 2008. The company focuses on developing innovative diagnostic solutions that enable rapid and accurate testing for various diseases, particularly in oncology and infectious diseases. With its flagship product, the Idylla™ platform, BIOCARTIS offers a unique, fully automated system that delivers real-time results from a simple sample, setting it apart in the diagnostics industry. The company has achieved significant milestones, including partnerships with leading pharmaceutical firms and a growing presence in key markets across Europe and beyond. Recognised for its commitment to advancing healthcare, BIOCARTIS continues to enhance its product portfolio, solidifying its position as a leader in the molecular diagnostics sector.
DitchCarbon Score
How does BIOCARTIS's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
BIOCARTIS's score of 21 is lower than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
BIOCARTIS's reported carbon emissions
BIOCARTIS, headquartered in Belgium, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that BIOCARTIS may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). As a result, the company's climate commitments remain unclear, and it appears that there are no significant emissions reduction achievements to highlight at this time.
How Carbon Intensive is BIOCARTIS's Industry?
How Carbon Intensive is BIOCARTIS's Location?
BIOCARTIS's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
BIOCARTIS has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.